Related references
Note: Only part of the references are listed.TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism
Marina Canyelles et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes
Mark M. Smits et al.
DIABETES & METABOLISM (2021)
High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide
Woongjae Yoo et al.
SCIENCE (2021)
Long-Term Effects of Bariatric Surgery on Gut Microbiota Composition and Faecal Metabolome Related to Obesity Remission
Maria Juarez-Fernandez et al.
NUTRIENTS (2021)
Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype
Jia V. Li et al.
MICROBIOME (2021)
Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes The Cardiovascular Health Study
Rozenn N. Lemaitre et al.
JAMA NETWORK OPEN (2021)
Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis
Parvin Dehghan et al.
OBESITY REVIEWS (2020)
Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung et al.
EBIOMEDICINE (2020)
Associations between physical activity and trimethylamine N-oxide in those at risk of type 2 diabetes
Stavroula Argyridou et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
Sifan Chen et al.
CELL METABOLISM (2019)
Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial
Yoriko Heianza et al.
GUT (2019)
Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies
Jiaqian Qi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevencion con Dieta Mediterranea (PREDIMED) trial
Christopher Papandreou et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2018)
Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function
Marina Canyelles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun et al.
NATURE MEDICINE (2018)
Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus
W. H. Wilson Tang et al.
CLINICAL CHEMISTRY (2017)
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
Gabriele Giacomo Schiattarella et al.
EUROPEAN HEART JOURNAL (2017)
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue
Rebecca C. Schugar et al.
CELL REPORTS (2017)
Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies
Yoriko Heianza et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Uncovering the trimethylamine-producing bacteria of the human gut microbiota
Silke Rath et al.
MICROBIOME (2017)
Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes
Zhilei Shan et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)
Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism
Rima Obeid et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis
Karolina Skagen et al.
ATHEROSCLEROSIS (2016)
Prospective Associations of Systemic and Urinary Choline Metabolites with Incident Type 2 Diabetes
Gard F. T. Svingen et al.
CLINICAL CHEMISTRY (2016)
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients
Mark M. Smits et al.
DIABETES OBESITY & METABOLISM (2016)
Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery
Marius Troseid et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2016)
An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery
Sophie H. Narath et al.
PLOS ONE (2016)
Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner
Ewa Gralka et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control
Daniel M. Mueller et al.
ATHEROSCLEROSIS (2015)
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Zeneng Wang et al.
CELL (2015)
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Ji Miao et al.
NATURE COMMUNICATIONS (2015)
γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Robert A. Koeth et al.
CELL METABOLISM (2014)
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Xiang Gao et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2014)
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study
Michael Lever et al.
PLOS ONE (2014)
Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation
Brian J. Bennett et al.
CELL METABOLISM (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
P Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
